Does SUVOREXANT Cause Product packaging quantity issue? 71 Reports in FDA Database
Wake Up Pain-Free — Sleep Like Never Before
Derila Ergo Pillow: ergonomic design, cooling tech. 75% OFF today.
According to the FDA Adverse Event Reporting System (FAERS), 71 reports of Product packaging quantity issue have been filed in association with SUVOREXANT (BELSOMRA). This represents 0.8% of all adverse event reports for SUVOREXANT.
71
Reports of Product packaging quantity issue with SUVOREXANT
0.8%
of all SUVOREXANT reports
0
Deaths
3
Hospitalizations
How Dangerous Is Product packaging quantity issue From SUVOREXANT?
Of the 71 reports, 3 (4.2%) required hospitalization.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SUVOREXANT. However, 71 reports have been filed with the FAERS database.
What Other Side Effects Does SUVOREXANT Cause?
Drug ineffective (2,855)
Nightmare (723)
Somnolence (639)
Abnormal dreams (588)
Insomnia (529)
Feeling abnormal (427)
Headache (421)
Hallucination (338)
No adverse event (327)
Fatigue (231)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
Which SUVOREXANT Alternatives Have Lower Product packaging quantity issue Risk?
SUVOREXANT vs SUZETRIGINE
SUVOREXANT vs SYMBICORT
SUVOREXANT vs SYNAGIS
SUVOREXANT vs SYNTHROID
SUVOREXANT vs TACROLIMUS